PharmaCyte Biotech, Inc.
NASDAQ:PMCB
Overview | Financials
Company Name | PharmaCyte Biotech, Inc. |
Symbol | PMCB |
Currency | USD |
Price | 1.6 |
Market Cap | 11,149,008 |
Dividend Yield | 0% |
52-week-range | 1.39 - 2.58 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joshua N. Silverman |
Website | https://pharmacyte.com |
An error occurred while fetching data.
About PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD